Molecular characterization and PCR detection of a deletional HPFH:: Application to rapid prenatal diagnosis for compound heterozygotes of this defect with β-thalassemia in a Chinese family

被引:0
作者
Xu, XM [1 ]
Li, ZQ [1 ]
Liu, ZY [1 ]
Zhong, XL [1 ]
Zhao, YZ [1 ]
Mo, QH [1 ]
机构
[1] First Mil Med Univ, Dept Cellular Biol & Med Genet, Guangzhou 510515, Peoples R China
关键词
beta-thalassemia; beta-globin gene cluster; thalassemia intermedia; fetal hemoglobin genetics; polymerase chain reaction (PCR); prenatal diagnosis;
D O I
10.1002/1096-8652(200011)65:3<183::AID-AJH1>3.0.CO;2-R
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hereditary persistence of fetal hemoglobin (HPFH) is one of the hemoglobinopathies in which the fetal gamma-globin genes remain active in adult life. Most HPFHs are caused by a large deletion involving a variable extent of DNA segment on the beta-globin gene cluster. We report the molecular defects associated with a deletional HPFH, which has previously been described in Cambodians and Vietnamese, in two unrelated Chinese individuals. To define the sequence around the breakpoints of the deletion, both the deletion junction fragment and the normal DNA across the breakpoints were cloned by PCR and sequenced. We found that the 5' breakpoint is located between nucleotides 986 and 987 upstream from the startpoint of the beta-globin gene, which further confirmed the Southeast Asian (SEA) HPFH deletion previously determined, whereas the 3' breakpoint, which is clarified for the first time by us, lies approximately 2.3 kb downstream from the 3' HS1 site of the beta-globin gene, It is suggested that deletions were the result of a non-homologous recombination event. Based on our novel sequence data, we designed a PCR amplification method with three primers bridging the 3' breakpoint. With this method and reverse dot blot (RDB) for detecting beta-thalassemia mutations, a Chinese family that had a 6-year-old propositus with severe thalassemia intermediate and that had requested prenatal diagnosis for the second pregnancy was found to be compound heterozygotes of HPFH defects with beta-thalassemia. The fetal genomic DNA diagnosis showed the same results as those in propositus, i.e., both of them inherited the deletion from their mother and inherited a codons 14-15 (+G) frameshift mutation causing beta-thalassemia from their father. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 6 条
  • [1] MOLECULAR CHARACTERIZATION OF BETA-THALASSEMIA IN SINGAPOREAN CHINESE - APPLICATION TO PRENATAL-DIAGNOSIS
    TAN, JAMA
    TAY, JSH
    KHAM, S
    CHIN, TM
    WONG, HB
    LAI, PS
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1993, 29 (06) : 461 - 463
  • [2] RAPID DIAGNOSIS OF BETA-THALASSEMIA BY MUTAGENICALLY SEPARATED POLYMERASE CHAIN-REACTION (MS-PCR) AND ITS APPLICATION TO PRENATAL-DIAGNOSIS
    CHANG, JG
    LU, JM
    HUANG, JM
    CHEN, JT
    LIU, HJ
    CHANG, CP
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (03) : 602 - 607
  • [3] Prenatal diagnosis and molecular cytogenetic characterization of hereditary complex chromosomal rearrangements in a Chinese family
    Tang, Dongling
    Wang, Bei
    Xie, Mingxia
    Li, Zeyu
    GINEKOLOGIA POLSKA, 2022, 93 (07) : 570 - 573
  • [4] Rapid detection of expansions by PCR and non-radioactive hybridization:: application for prenatal diagnosis of myotonic dystrophy
    Zühlke, C
    Atici, J
    Martorell, L
    Gembruch, U
    Kohl, M
    Göpel, W
    Schwinger, E
    PRENATAL DIAGNOSIS, 2000, 20 (01) : 66 - 69
  • [5] Prenatal Diagnosis and Molecular Cytogenetic Characterization of Xp22.32p22.31 Microduplication in a Chinese family
    Cui, Weixin
    Li, Xi
    Jin, Yan
    Zhang, Juan
    GINEKOLOGIA POLSKA, 2023, 94 (03) : 188 - 190
  • [6] Direct PCR assays without DNA extraction for rapid detection of hemoglobin Constant Spring and Pakse' genes: application for carrier screening and prenatal diagnosis
    Wichian, Phongsathorn
    Yamsri, Supawadee
    Chaibunruang, Attawut
    KerdKaew, Cholthicha
    Thongsee, Dhanawan
    Srivorakun, Hataichanok
    Fucharoen, Supan
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2021, 81 (07) : 557 - 563